| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292606 | Gastroenterology | 2015 | 27 Pages |
Abstract
Optimal management of UC requires careful patient assessment, evidence-based use of existing therapies, and thorough assessment to define treatment success.
Keywords
TPMTTNFCAGMMXIBDRCTFMT5-aminosalicylateRandomized controlled trialantidrug antibodiesInflammatory bowel diseasethiopurineThiopurine methyltransferaseRelative riskAnti–Tumor Necrosis Factorconfidence intervaltumor necrosis factorGradenot significantodds ratioADAVedolizumabProbioticsCorticosteroidUlcerative colitis
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Brian Bressler, John K. Marshall, Charles N. Bernstein, Alain Bitton, Jennifer Jones, Grigorios I. Leontiadis, Remo Panaccione, A. Hillary Steinhart, Francis Tse, Brian Feagan,